CLDN5 and stroke disorder: In our study, quantitative real-time PCR analyses revealed that, in wild-type mice, the mRNA level of occludin, as well as those of claudin-5 and ZO-1, decreased starting from the acute phase at 3 h after stroke, and the decline continued into the chronic phase 48 days after stroke (Fig. 1B–D).